• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Zeposia will Flop. Fallout will affect many

“unofficial offer” Ha! The jokes on you.... I hope that I am your hiring manager- you arent getting crap. DM’s have first right of refusal, and I am bringing in most of my team from my previous company. Oh yea, several other managers will be doing the same thing, so I wouldnt spend too much of your “unofficial offer”

LIAR!!
 
















































They need to reorganize the top first. Lousy sales/marketing management to say the least. SL/MC/JR all a joke. Idk all the DBMs to mention, I’m sure there are a few good ones, definitely bad ones. I wonder if the failed approach in leadership will extend into UC?
 




























BMS has a true lack of understanding on how the MS is managed and needs to model biogen for example. Ignorance has created a level of distrust from top talent here which is difficult to change.